Experimental Validation and Pan-Cancer Analysis Identified COL10A1 as a Novel Oncogene and Potential Therapeutic Target in Prostate Cancer

Using bioinformatic analysis of data from the most recent databases, investigators extensively elucidated the role played by COL10A1 in terms of its expression patterns, prognostic implications, and immune efficacy across a pan-cancer spectrum.